Drug delivery by red blood cells
Drug delivery is a growing field of interdisciplinary activities that combine the use of new
materials with the biochemical properties of selected drugs, with the aim of improving their …
materials with the biochemical properties of selected drugs, with the aim of improving their …
The International Society of Heart and Lung Transplantation Guidelines for the care of heart transplant recipients
MR Costanzo, A Dipchand, R Starling… - The Journal of heart and …, 2010 - Elsevier
CHAIR: Costanzo MR: Midwest Heart Foundation, Lombard Illinois, USA TASK FORCE 1:
Dipchand A: Hospital for Sick Children, Toronto Ontario, Canada; Starling R: Cleveland …
Dipchand A: Hospital for Sick Children, Toronto Ontario, Canada; Starling R: Cleveland …
Sirolimus: the evidence for clinical pharmacokinetic monitoring
SB Stenton, N Partovi, MHH Ensom - Clinical pharmacokinetics, 2005 - Springer
This review seeks to apply a decision-making algorithm to establish whether clinical
pharmacokinetic monitoring (CPM) of sirolimus (rapamycin) in solid organ transplantation is …
pharmacokinetic monitoring (CPM) of sirolimus (rapamycin) in solid organ transplantation is …
Different effects of FK506, rapamycin, and mycophenolate mofetil on glucose-stimulated insulin release and apoptosis in human islets
JD Johnson, Z Ao, P Ao, H Li, LJ Dai, Z He… - Cell …, 2009 - journals.sagepub.com
Pancreatic islet transplantation has the potential to be an effective treatment for type 1
diabetes mellitus. While recent improvements have improved 1-year outcomes, follow-up …
diabetes mellitus. While recent improvements have improved 1-year outcomes, follow-up …
Immunophilin-loaded erythrocytes as a new delivery strategy for immunosuppressive drugs
Cyclosporine A (CsA) and tacrolimus (also known as FK506) are natural compounds with
immunosuppressive activity that have improved the outcome of organ transplantation …
immunosuppressive activity that have improved the outcome of organ transplantation …
Mechanisms of pharmacokinetic and pharmacodynamic drug interactions associated with ritonavir‐enhanced tipranavir
M Vourvahis, ADM Kashuba - Pharmacotherapy: The Journal …, 2007 - Wiley Online Library
Tipranavir is a nonpeptidic protease inhibitor that has activity against human
immunodeficiency virus strains resistant to multiple protease inhibitors. Tipranavir 500 mg is …
immunodeficiency virus strains resistant to multiple protease inhibitors. Tipranavir 500 mg is …
Label-free quantification of Tacrolimus in biological samples by atomic force microscopy
In the present paper we describe an atomic force microscopy (AFM)-based method for the
quantitative analysis of FK506 (Tacrolimus) in whole blood (WB) samples. Current reference …
quantitative analysis of FK506 (Tacrolimus) in whole blood (WB) samples. Current reference …
Treatment with Tacrolimus and Sirolimus Reveals No Additional Adverse Effects on Human Islets In Vitro Compared to Each Drug Alone but They Are Reduced by …
K Kloster-Jensen, A Sahraoui, NT Vethe… - Journal of diabetes …, 2016 - Wiley Online Library
Tacrolimus and sirolimus are important immunosuppressive drugs used in human islet
transplantation; however, they are linked to detrimental effects on islets and reduction of …
transplantation; however, they are linked to detrimental effects on islets and reduction of …
Incorporation of Gene‐Environment Interaction Terms Improved the Predictive Accuracy of Tacrolimus Stable Dose Algorithms in Chinese Adult Renal Transplant …
J Tang, J Xu, YL Zhang, R Liu, MZ Liu… - The Journal of …, 2019 - Wiley Online Library
The narrow therapeutic window of tacrolimus necessitates daily monitoring and predictive
algorithms based on genetic and nongenetic factors. In this study, we constructed predictive …
algorithms based on genetic and nongenetic factors. In this study, we constructed predictive …
Bioequivalence of two tacrolimus formulations under fasting conditions in healthy male subjects
P Mathew, J Mandal, K Patel, K Soni, G Tangudu… - Clinical …, 2011 - Elsevier
BACKGROUND: Tacrolimus is a macrolide immunosuppressant indicated for prophylaxis of
transplant rejection. The European regulatory authorities require comparative bioavailability …
transplant rejection. The European regulatory authorities require comparative bioavailability …